4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of plasmodium falciparum

Chemical Biology and Drug Design

Volumn 81, Issue 5, 2013, Pages 625-630

  Manohar, Sunny ^a   Khan, Shabana I ^b   Rawat, Diwan S ^a  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Antimalarial; Hybrids; Plasmodium falciparum

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; CHLOROQUINE; DOXORUBICIN; TRIAZINE DERIVATIVE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; COVALENT BOND; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HYBRID; MAMMAL CELL; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; CERCOPITHECUS AETHIOPS; CHLOROQUINE; DRUG RESISTANCE; HEP G2 CELLS; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TRIAZINES; VERO CELLS;

MAMMALIA; PLASMODIUM FALCIPARUM;

EID: 84876884044     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12108     Document Type: Article

References (43)

1. Kumar N., Singh R., Rawat D.S. (2012) Tetraoxanes: synthetic and medicinal chemistry perspective. Med Res Rev;32:581-610.
2. WHO (2009) World Malaria Report. WHO http://www.who.int/malaria/world_malaria_report_2009/en/index.html (accessed on 26 January 2013).
3. Krogstad D.J. (1996) Malaria as a re-emerging disease. Epidemiol Rev;18:77-89.
4. Greenwood B.M., Bojang K., Whitty C.J., Targett G.A. (2005) Malaria. Lancet;365:1487-1498.
5. O'Neill P.M., Bray P.G., Hawley S.R., Ward S.A., Park B.K. (1998) 4-Aminoquinolines-past, present, and future: a chemical perspective. Pharmacol Ther;77:29-58.
6. Martin S.K., Oduola A.M., Milhous W.K. (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science;235:899-901.
7. Burgess S.J., Selzer A., Kelly J.X., Smilkstein M.J., Riscoe M.K., Peyton D.H. (2006) A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum. J Med Chem;49:5623-5625.
8. Mutabingwa T.K. (2005) Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!. Acta Trop;95:305-315.
9. Kumar N., Sharma M., Rawat D.S. (2011) Medicinal chemistry perspectives of trioxanes and tetraoxanes. Curr Med Chem;18:3889-3928.
10. Dong Y., Tang Y., Chollet J., Matile H., Wittlin S., Charman S.A., Charman W.N. et al. (2006) Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1, 2, 4-trioxolanes. Bioorg Med Chem;14:6368-6382.
11. Posner G.H., Paik I.H., Chang W., Borstnik K., Sinishtaj S., Rosenthal A.S., Shapiro T.A. (2007) Malaria-infected mice are cured by a single dose of novel artemisinin derivatives. J Med Chem;50:2516-2519.
12. Paik I.H., Xie S., Shapiro T.A., Labonte T., Narducci Sarjeant A.A., Baege A.C., Posner G.H. (2006) Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity. J Med Chem;49:2731-2734.
13. Vennerstrom L., Arbe-Barnes S., Brun R., Charman S.A., Chiu F.C., Chollet J., Dong Y. et al. (2004) Identification of an antimalarial synthetic trioxolane drug development candidate. Nature;430:900-904.
14. O'Neill P.M., Posner G.H. (2004) A medicinal chemistry perspective on artmeisinin and related endoperoxides. J Med Chem;47:2945-2964.
15. Jambou R., Legrand E., Niang M., Khim N., Lim P., Volney B., Ekala M.T., Bouchier C., Esterre P., Fandeur T., Mercereau-Puijalon O. (2005) Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase 6. Lancet;366:1960-1963.
16. Egan T.J. (2001) Structure-function relationships in chloroquine and related 4-aminoquinoline antimalarials. Mini Rev Med Chem;1:113-123.
17. Dominguez J.N. (2002) Chemotherapeutic agents against malaria: what next after chloroquine? Curr Top Med Chem;2:1173-1185.
18. Delarue S., Girault S., Maes L., Debreu-Fontaine M.A., Labaeid M., Grellier P., Sergheraert C. (2001) Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines. J Med Chem;44:2827-2833.
19. O'Neill P.M., Willock D.J., Hawley S.R., Bray P.G., Storr R.C., Ward S.A., Park B.K. (1997) Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues. J Med Chem;40:437-448.
20. Madrid P.B., Liou A.P., DeRisi J.L., Guy R.K. (2006) Incorporation of an intramolecular hydrogen-bonding motif in the side chain of 4-aminoquinolines enhances activity against drug-resistant P. falciparum. J Med Chem;49:4535-4543.
21. Riccio E.S., Lee P.S., Winegar R.A., Krogstad D.J., De D., Mirsalis J.C. (2001) Genetic toxicology testing of the antimalarial drugs chloroquine and a new analog, AQ-13. Environ Mol Mutagen;38:69-79.
22. Ridley R.G., Hofheinz H., Matile H., Jacquet C., Dorn A., Masciadri R., Jolidon S., Richter W.F., Guenzi A., Girometta M.A., Urwyler H., Huber W., Thiathong S., Peters W. (1996) 4-Aminoquinoline analogues of CQ with shortened side chains retain activity against CQ-resistant Plasmodium falciparum. Antimicrob Agents Chemother;40:1846-1854.
23. De D., Krogstad F.M., Byers L.D., Krogstad D.J. (1998) Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines. J Med Chem;41:4918-4926.
24. Hawley S.R., Bray P.G., Park B.K., Ward S.A. (1996) Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Mol Biochem Parasitol;80:15-25.
25. Stocks P.A., Raynes K.J., Bray P.G., Park B.K., O'Neill P.M., Ward S.A. (2002) Novel short chain chloroquine analogues retain activity against chloroquine resistant K1 Plasmodium falciparum. J Med Chem;45:4975-4983.
26. Madrid P.B., Wilson N.T., DeRisi J.L., Guy R.K. (2004) Parallel synthesis and antimalarial screening of a 4-aminoquinoline library. J Comb Chem;6:437-442.
27. Dechy-Cabaret O., Benoit-Vical F., Robert A., Meunier B. (2000) Preparation and antimalarial activities of "trioxaquines", new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. ChemBioChem;1:281-283.
28. Peric M., Fajdetic A., Rupc R., Alihodzic S., Ziher D., Krajacic M.B., Smith K.S. et al. (2012) Antimalarial activity of 9a-n substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin. J Med Chem;55:1389-1401.
29. Singh C., Malik H., Puri S.K. (2004) Synthesis and antimalarial activity of a new series of trioxaquines. Bioorg Med Chem;12:1177-1182.
30. Chiyanzu I., Clarkson C., Smith P.J., Lehman J., Gut J., Rosenthal P.J., Chibale K. (2005) Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives. Bioorg Med Chem;13:3249-3261.
31. Biot C., Glorian G., Maciejewski L.A., Brocard J.S. (1997) Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analog. J Med Chem;40:3715-3718.
32. Manohar S., Khan S.I., Rawat D.S. (2010) Synthesis, antimalarial activity and cytotoxicity of 4-aminoquinoline-triazine conjugates. Bioorg Med Chem Lett;20:322-325.
33. Manohar S., Khan S.I., Rawat D.S. (2011) Synthesis of 4-aminoquinoline-1, 2, 3-triazole and 4-aminoquinoline-1, 2, 3-triazole-1, 3, 5-triazine hybrids as potential antimalarial agents. Chem Biol Drug Des;78:124-136.
34. Manohar S., Rajesh U.C., Khan S.I., Tekwani B.L., Rawat D.S. (2012) Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity. ACS Med Chem Lett;3:555-559.
35. Wenzel N.I., Chavain N., Wang Y., Friebolin W., Maes L., Pradines B., Lanzer M., Yardley V., Brun R., Herold-Mende C., Biot C., Toth K., Davioud-Charvet E. (2010) Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and mannich bases: interaction with DNA. J Med Chem;53:3214-3226.
36. Lombard M.C., N'Da D.D., Breytenbach J.C., Smith P.J., Lategan C.A. (2011) Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids. Bioorg Med Chem Lett;21:1683-1686.
37. Sunduru N., Sharma M., Srivastava K., Rajakumar S., Puri S.K., Saxena J.K., Chauhan P.M.S. (2009) Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity. Bioorg Med Chem;17:6451-6462.
38. Melato S., Prosperi D., Coghi P., Basilico N., Monti D. (2008) A combinatorial approach to 2, 4, 6-trisubstituted triazines with potent antimalarial activity: combining conventional synthesis and microwave-assistance. ChemMedChem;3:873-876.
39. Atheaya H., Khan S.I., Mamgain R., Rawat D.S. (2008) Synthesis, thermal stability, antimalarial activity of symmetrically and asymmetrically substituted tetraoxanes. Bioorg Med Chem Lett;18:1446-1449.
40. Kumar N., Khan S.I., Beena, Rajalakshmi G., Kumaradhas P., Rawat D.S. (2009) Synthesis, antimalarial activity and cytotoxicity of substituted 3, 6-diphenyl-[1, 2, 4, 5]tetraoxanes. Bioorg Med Chem;17:5632-5638.
41. Kumar N., Khan S.I., Sharma M., Atheaya H., Rawat D.S. (2009) Iodine-catalyzed one-pot synthesis and antimalarial activity evaluation of symmetrically and asymmetrically substituted 3, 6-diphenyl[1, 2, 4, 5]tetraoxanes. Bioorg Med Chem Lett;19:1675-1677.
42. Kumar N., Khan S.I., Atheaya H., Mamgain R., Rawat D.S. (2011) Synthesis and in vitro antimalarial activity of tetraoxane-amine/amide conjugates. Eur J Med Chem;46:2816-2827.
43. Natarajan J.K., Alumasa J.N., Yearick K., Ekoue-Kovi K.A., Casabianca L.B., de Dios A.C., Wolf C., Roepe P.D. (2008) 4-N-, 4-S-, and 4-O-chloroquine analogues: influence of side chain length and quinolyl nitrogen pKa on activity vs chloroquine resistant malaria. J Med Chem;51:3466-3479.